ANIXA BIOSCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ANIXA BIOSCIENCES, INC. (ANIX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $766.42 thousand for the 6-month period ending 2019-04-30, per its 10-Q filed 2019-06-12.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-06-12
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-04-30 was -$330.33K, a 124.92% decline year-over-year.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-01-31 was $1.10M.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-10-31 was $464.79K, a 69.13% decline year-over-year.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-07-31 was -$1.58M.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$283.48K, a 133.31% decline from fiscal 2017.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $851.05K.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.88M, a 286.60% decline from fiscal 2015.
- ANIXA BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $1.01M, a 59.08% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-04-30 | -$330.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $766.42K 10-Q · filed 2019-06-12 | $1.23M derived: sum of 3 quarters · filed 2019-06-12 | -$350.14K derived: sum of 4 quarters · filed 2019-06-12 |
| 2019-01-31 | $1.10M 10-Q · filed 2019-03-13 | $1.56M derived: sum of 2 quarters · filed 2019-03-13 | -$19.81K derived: sum of 3 quarters · filed 2019-03-13 | $1.31M derived: sum of 4 quarters · filed 2019-06-12 |
| 2018-10-31 | $464.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | -$1.12M derived: sum of 2 quarters · filed 2019-01-11 | $209.03K derived: sum of 3 quarters · filed 2019-06-12 | -$283.48K 10-K · filed 2019-01-11 |
| 2018-07-31 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | -$255.76K derived: sum of 2 quarters · filed 2019-06-12 | -$748.27K 10-Q · filed 2018-09-07 | $757.33K derived: sum of 4 quarters · filed 2019-06-12 |
| 2018-04-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $833.08K 10-Q · filed 2019-06-12 | $2.34M derived: sum of 3 quarters · filed 2019-06-12 | $1.30M derived: sum of 4 quarters · filed 2019-06-12 |
| 2018-01-31 | -$492.51K 10-Q · filed 2019-03-13 | $1.01M derived: sum of 2 quarters · filed 2019-03-13 | -$30.03K derived: sum of 3 quarters · filed 2019-03-13 | $1.45M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-10-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $462.48K derived: sum of 2 quarters · filed 2019-01-11 | $1.94M derived: sum of 3 quarters · filed 2019-01-11 | $851.05K 10-K · filed 2019-01-11 |
| 2017-07-31 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | $433.81K derived: sum of 2 quarters · filed 2018-09-07 | -$654.55K 10-Q · filed 2018-09-07 | -$215.48K derived: sum of 4 quarters · filed 2018-09-07 |
| 2017-04-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-06-11 | $388.57K 10-Q · filed 2018-06-11 | $827.65K derived: sum of 3 quarters · filed 2018-06-11 | $264.58K derived: sum of 4 quarters · filed 2018-06-11 |
| 2017-01-31 | -$1.09M 10-Q · filed 2018-03-09 | -$649.29K derived: sum of 2 quarters · filed 2018-03-09 | -$1.21M derived: sum of 3 quarters · filed 2018-03-09 | -$2.58M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-10-31 | $439.08K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | -$124.00K derived: sum of 2 quarters · filed 2018-01-09 | -$1.49M derived: sum of 3 quarters · filed 2018-01-09 | -$1.88M 10-K · filed 2018-01-09 |
| 2016-07-31 | -$563.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$1.93M derived: sum of 2 quarters · filed 2017-09-08 | -$2.32M 10-Q · filed 2017-09-08 | -$3.11M derived: sum of 4 quarters · filed 2017-09-08 |
| 2016-04-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | -$1.76M 10-Q · filed 2017-05-26 | -$2.55M derived: sum of 3 quarters · filed 2017-05-26 | -$3.47M derived: sum of 4 quarters · filed 2017-05-26 |
| 2016-01-31 | -$388.39K 10-Q · filed 2017-03-16 | -$1.18M derived: sum of 2 quarters · filed 2017-03-16 | -$2.10M derived: sum of 3 quarters · filed 2017-03-16 | -$3.83M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-10-31 | -$791.63K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | -$1.71M derived: sum of 2 quarters · filed 2016-12-08 | -$3.44M derived: sum of 3 quarters · filed 2016-12-08 | $1.01M 10-K · filed 2016-12-08 |
| 2015-07-31 | -$919.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | -$2.65M derived: sum of 2 quarters · filed 2016-08-19 | $1.80M 10-Q · filed 2016-08-19 | $1.51M derived: sum of 4 quarters · filed 2016-08-19 |
| 2015-04-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $2.72M 10-Q · filed 2016-05-20 | $2.43M derived: sum of 3 quarters · filed 2016-05-20 | $5.46M derived: sum of 4 quarters · filed 2016-05-20 |
| 2015-01-31 | $4.45M 10-Q · filed 2016-02-19 | $4.16M derived: sum of 2 quarters · filed 2016-02-19 | $7.19M derived: sum of 3 quarters · filed 2016-02-19 | $7.03M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-10-31 | -$290.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $2.74M derived: sum of 2 quarters · filed 2015-12-23 | $2.59M derived: sum of 3 quarters · filed 2015-12-23 | $2.46M 10-K · filed 2015-12-23 |
| 2014-07-31 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $2.88M derived: sum of 2 quarters · filed 2015-08-18 | $2.75M 10-Q · filed 2015-08-18 | $2.67M derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-04-30 | -$158.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | -$280.45K 10-Q · filed 2015-05-22 | -$364.31K derived: sum of 3 quarters · filed 2015-05-22 | -$656.03K derived: sum of 4 quarters · filed 2015-05-22 |
| 2014-01-31 | -$122.03K 10-Q · filed 2015-03-09 | -$205.89K derived: sum of 2 quarters · filed 2015-03-09 | -$497.61K derived: sum of 3 quarters · filed 2015-03-09 | -$937.21K derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-10-31 | -$83.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | -$375.58K derived: sum of 2 quarters · filed 2015-01-29 | -$815.18K derived: sum of 3 quarters · filed 2015-01-29 | $558.48K 10-K · filed 2015-01-29 |
| 2013-07-31 | -$291.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$731.32K derived: sum of 2 quarters · filed 2014-09-15 | $642.34K 10-Q · filed 2014-09-15 | $880.50K derived: sum of 4 quarters · filed 2014-09-15 |
| 2013-04-30 | -$439.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $934.06K 10-Q · filed 2014-06-16 | $1.17M derived: sum of 3 quarters · filed 2014-06-16 | $1.14M derived: sum of 4 quarters · filed 2014-06-16 |
| 2013-01-31 | $1.37M 10-Q · filed 2014-03-17 | $1.61M derived: sum of 2 quarters · filed 2014-03-17 | $1.58M derived: sum of 3 quarters · filed 2014-03-17 | $1.25M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $238.16K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $208.96K derived: sum of 2 quarters · filed 2014-01-17 | -$123.34K derived: sum of 3 quarters · filed 2014-01-17 | -$434.35K 10-K/A · filed 2014-01-17 |
| 2012-07-31 | -$29.20K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | -$361.50K derived: sum of 2 quarters · filed 2013-09-20 | -$672.51K 10-Q/A · filed 2013-09-20 | -$449.87K derived: sum of 4 quarters · filed 2013-09-20 |
| 2012-04-30 | -$332.31K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | -$643.31K 10-Q/A · filed 2013-06-19 | -$420.67K derived: sum of 3 quarters · filed 2013-06-19 | -$216.37K derived: sum of 4 quarters · filed 2013-06-19 |
| 2012-01-31 | -$311.00K 10-Q/A · filed 2013-03-25 | -$88.36K derived: sum of 2 quarters · filed 2013-03-25 | $115.94K derived: sum of 3 quarters · filed 2013-03-25 | -$515.92K derived: sum of 4 quarters · filed 2013-03-25 |
| 2011-10-31 | $222.64K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $426.94K derived: sum of 2 quarters · filed 2013-01-29 | -$204.92K derived: sum of 3 quarters · filed 2013-01-29 | -$320.08K 10-K · filed 2013-01-29 |
| 2011-07-31 | $204.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | -$427.56K derived: sum of 2 quarters · filed 2012-09-14 | -$542.71K 10-Q · filed 2012-09-14 | -$857.56K derived: sum of 4 quarters · filed 2012-09-14 |
| 2011-04-30 | -$631.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | -$747.01K 10-Q · filed 2012-06-14 | -$1.06M derived: sum of 3 quarters · filed 2012-06-14 | |
| 2011-01-31 | -$115.16K 10-Q · filed 2012-03-16 | -$430.00K derived: sum of 2 quarters · filed 2012-03-16 | ||
| 2010-10-31 | -$314.84K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | -$357.13K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | -$42.28K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |